---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-159143"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2024-06-11T23:59:59+00:00"
generated_at: "2026-06-01T05:05:23.086542+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences directors Koppel and Shah resign; shareholders approve doubling authorized shares to 120M

## Summary
- Adam Koppel and Rajeev Shah resigned from the Board effective June 11, 2024; no disagreement cited.
- Shareholders approved increase of authorized common stock from 60M to 120M shares.
- Equity incentive plan amended to add 2M shares; total available for issuance increased accordingly.
- Four Class III directors elected: Martin Freed, Ilan Ganot, Georgia Keresty, Ian Smith.
- Advisory vote on executive compensation held every year; PricewaterhouseCoopers ratified as auditor for FY2024.

## SEC filing metadata
- accession: 0001193125-24-159143
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2024-06-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/0001193125-24-159143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/d845618d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-159143
- JSON: https://secwatch.observer/filing/0001193125-24-159143.json
- Plain text: https://secwatch.observer/filing/0001193125-24-159143.txt

## Key facts
- Executive change
  Adam Koppel resigned as Director at Solid Biosciences Inc..
  - Action: resigned
  - Role: Director
  source text: Adam Koppel notified Solid Biosciences Inc. (the “Company”) of his decision to resign as a member of the Company’s Board of Directors (the “Board”), effective as of June 11, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/0001193125-24-159143-index.htm
- Executive change
  Rajeev Shah resigned as Director at Solid Biosciences Inc..
  - Action: resigned
  - Role: Director
  source text: Rajeev Shah notified the Company of his decision to resign as a member of the Board, effective as of June 11, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1707502/000119312524159143/0001193125-24-159143-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.